| Trademark Snap Shot Publication & Issue Review Stylesheet (Table presents the data on Publication & Issue Review Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 77113149 | FILING DATE | 02/22/2007 |
| REG NUMBER | 0000000 | REG DATE | 07/17/2007 |
| REGISTER | SUPPLEMENTAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | TIERNEY, MARGERY ANN |
L.O. ASSIGNED | 111 |
PUB INFORMATION |
|||
| RUN DATE | 06/13/2007 | ||
| PUB DATE | N/A | ||
| STATUS | 681-PUBLICATION/ISSUE REVIEW COMPLETE | ||
| STATUS DATE | 06/12/2007 | ||
| LITERAL MARK ELEMENT | KRINGLE PHARMA, INC. | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | NO | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | YES | 44E | YES | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | KRINGLE PHARMA, INC. |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Kringle Pharma, Inc. |
| ADDRESS | Senri Asahi Hankyu Bldg. 8F 5-3 Shinsenrihigashimachi 1-chome; Toyonaka Osaka, 560-0082 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Japan |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical, veterinary preparations for liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer and sanitary preparations for medical use; central nervous system stimulants; hair growth stimulant; antipyretic analgesics; anti-epileptics; analeptics; hypnotic sedatives; general anesthetics; anti-motion sickness preparations; pharmaceutical preparations acting on the peripheral nervous system; local anesthetics; skeletal muscle relaxants; anhidrotics; autonomics; antispasmodics; diaphoretics; pharmaceutical preparations acting on the sensory organs; ophthalmic preparations; agents for otic and nasal use, namely, nasal spray preparations, eye washes, eye drops, irrigating solutions for eye use; treatment for eye infection, macular degeneration, retinopathy, rhinitis, sinusitis; pharmaceutical antiallergic preparations; antihistaminics; cardiovascular treatment preparations; cardiotonics; antihypertensives; vasoconstrictors; capillary stabilizers; cerebral hemorrhage prophylactic preparations; antiarrhythmic preparations; diuretics; pharmaceutical preparations acting on respiratory organs; respiratory stimulants; anti-cough drops; antitussive expectorants; pharmaceutical preparations acting on digestive organs; gastrointestinal cleaning agents; clysters; evacuants (purgatives); stomachics and digestives; pharmaceutical preparations for oral use, for oral inflammation; emetics; pharmaceutical preparations for dental purposes for gingivostomatitis, alveolar abscess, alveoloclasia; antacids; antiemetics; castor oil for medical purposes; cholagogues; hormones for medical purposes; thyroid and para-thyroid hormone preparations; mixed hormone preparations; estrogen preparations; pancreas hormone preparations; salivary gland hormone preparations; androgen preparations; pituitary hormone preparations; adrenal hormone preparations; pharmaceutical preparations acting on uro-genital and anal organs; oxytocics; anti-hemorrhoidals; emmenagogues; contraceptives; medicated skin care preparations; pharmaceutical preparations for purulence; anti-dermoinfectives; antimicrobials for dermatologic use; astringents; anti-inflammatory agents; analgesics; anti-itchings; talcum powder; medicated baby oils; medicated baby powders; medicated bath preparations; vitamin preparations; cod-liver oil drops; mixed vitamin preparations; vitamin A preparations; vitamin C preparations; vitamin D preparations; vitamin B preparations; multi-vitamin preparations; amino acid preparations for medical purposes; threonine preparations; tryptophane preparations; methionine preparations; lysine preparations; royal jelly for medical purposes; calcium supplements; chondroitin preparations; protein and amino acid preparations for medical purposes; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, lupus erhthematosus; mineral preparations for medical use; anticoagulants; blood substitutes for human and veterinary use; blood plasma; hemostatics; pharmaceutical preparations affecting metabolism; antidotes; enzyme preparations for medical purposes; lactagogues; lipotropic factor preparations; pharmaceutical preparations for the treatment of habitual intoxication; pharmaceutical preparations for activating cellular function; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; pharmaceutical preparations for treating physically caused lesions; pharmaceutical preparations for treating heatstroke; radiation sickness treating drugs; pharmaceutical preparations for treating chemically caused disorders, namely, chemical burn, side effect of anticancer drugs, immunosuppresants; chlorine-detoxication preparations; arsenic-detoxication preparations; benzol-detoxication preparations; antibiotic preparations; erythromycin preparations; chloramphenicol preparations; colistin-polymixin preparations; salkomycin preparations; streptomycin preparations; thiolutin preparations; tetracycline preparations; trichomycin preparations; mixed antibiotic preparations; penicillin preparations; chemotherapeutics; antisyphilitics; antituberculous preparations; sulfonamide preparations; antileprotic preparations; biological preparations for medical purposes; antitoxic sera; antitoxins; mixed biological preparations for medical purposes; preparations for biological tests for medical purposes; toxoids; vaccines; preparations for destroying parasites; anthelmintics; odor neutralizing preparations for use on drugs; pharmaceutical excipients; diagnostic preparations for medical use; X-ray contrast agents; diagnostic reagents for medical use; diagnostic media for bacteriological cultures for medical use; radio isotope markers for therapeutic or diagnostic use; opium alkaloid preparations; synthetic narcotics; coca alkaloid preparations; mosquito-repellent incenses; germicides and fungicides; rodenticides; insecticides; fumigants; herbicides, namely, weedkillers; insect-repellents; antiseptics |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| DISCLAIMER W/PREDETER TXT | INC. |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | N/A |
| APPLICATION NO. | N/A |
| APPLICATION FILING DATE | N/A |
| FOREIGN REG NO. | 4811451 |
| FOREIGN REG DATE | 10/22/2004 |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | 10/22/2014 |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 06/12/2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 009 |
| 06/12/2007 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | 008 |
| 06/12/2007 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 007 |
| 06/12/2007 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 006 |
| 06/09/2007 | DOCK | D | ASSIGNED TO EXAMINER | 005 |
| 05/03/2007 | AMPX | O | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 004 |
| 05/03/2007 | ALIE | A | ASSIGNED TO LIE | 003 |
| 04/05/2007 | PARI | I | TEAS PRELIMINARY AMENDMENT RECEIVED | 002 |
| 02/27/2007 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Amy E. Schmid |
| CORRESPONDENCE ADDRESS | AMY E. SCHMID WENDEROTH, LIND & PONACK, L.L.P. 2033 K ST NW STE 800 WASHINGTON, DC 20006-1021 |
| DOMESTIC REPRESENTATIVE | Amy E. Schmid |